Insulin aspart, recombinant Subcutaneous and Shingrix
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Shingrix and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: zoster vaccine, inactivated
Brand name: Shingrix
Synonyms: Shingrix Vaccine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Shopko Allergy Relief-D (Ceti)
- Insulin aspart, recombinant Subcutaneous-Shopko Nasal Decongestant
- Insulin aspart, recombinant Subcutaneous-Shopko Nasal Decongestant Max
- Insulin aspart, recombinant Subcutaneous-Short ragweed pollen allergen extract Sublingual
- Insulin aspart, recombinant Subcutaneous-Signifor
- Insulin aspart, recombinant Subcutaneous-Signifor (Pasireotide Extended-Release Injection)
- Shingrix-Insulin degludec
- Shingrix-Insulin Degludec (U-100) Prefilled Pens
- Shingrix-Insulin Degludec (U-100) Vials
- Shingrix-Insulin Degludec (U-200) Prefilled Pens
- Shingrix-Insulin degludec and liraglutide
- Shingrix-Insulin degludec and liraglutide Subcutaneous